Higher breast cancer conspicuity on dbPET compared to WB-PET/CT

This publication has 21 references indexed in Scilit:

• Comparative Analysis of Imaging Sensitivity of Positron Emission Mammography and Whole-Body PET in Relation to Tumor Size
  Clinical Nuclear Medicine, 2015
• Value of 18F-FDG PET/CT for Early Prediction of Pathologic Response (by Residual Cancer Burden Criteria) of Locally Advanced Breast Cancer to Neoadjuvant Chemotherapy
  Clinical Nuclear Medicine, 2014
• Diagnostic Performance of Dedicated Positron Emission Mammography Using Fluorine-18-Fluorodeoxyglucose in Women With Suspicious Breast Lesions: A Meta-analysis
  Clinical Breast Cancer, 2014
• FDG PET/CT during neoadjuvant chemotherapy may predict response in ER-positive/HER2-negative and triple negative, but not in HER2-positive breast cancer
  The Breast, 2013
• Interpretation of Positron Emission Mammography and MRI by Experienced Breast Imaging Radiologists: Performance and Observer Reproducibility
  American Journal of Roentgenology, 2011
• Breast Cancer: Comparative Effectiveness of Positron Emission Mammography and MR Imaging in Presurgical Planning for the Ipsilateral Breast
  Radiology, 2011
• Initial Characterization of a Dedicated Breast PET/CT Scanner During Human Imaging
  Journal of Nuclear Medicine, 2009
• A systematic review of FDG-PET in breast cancer
  Medical Oncology, 2009
• FDG PET and other imaging modalities in the primary diagnosis of suspicious breast lesions
  European Journal of Nuclear Medicine and Molecular Imaging, 2004
• Breast Imaging With Positron Emission Tomography and Fluorine-18 Fluorodeoxyglucose: Use and Limitations
  Journal of Clinical Oncology, 2000